US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Protalix BioTherapeutics

2.04

-0.0880-4.13%

Volume:355.23K

Turnover:741.38K

Market Cap:164.22M

PE:-24.91

High:2.14

Open:2.13

Low:2.04

Close:2.13

52wk High:3.19

52wk Low:1.32

Shares:80.42M

Float Shares:60.76M

Volume Ratio:0.50

T/O Rate:0.58%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0820

EPS(LYR):-0.0841

ROE:-14.44%

ROA:-4.41%

PB:3.40

PE(LYR):-24.29

Loading ...

Overview Company News Filings

Protalix BioTherapeutics Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Top Midday Decliners

MT Newswires Live

Protalix Biotherapeutics Reports Fiscal Year 2025 Financial And Business Results

Protalix BioTherapeutics FY 2025 R&D expenses rose 51% to USD 19.57 million as net loss totaled USD 6.6 million

Press Release: Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results

Protalix BioTherapeutics to report fiscal 2025 results and host conference call

EU Approves Four‑week Dosing Option For Chiesi and Protalix’s Elfabrio

European Commission approves every-four-weeks Elfabrio dosing regimen for Protalix BioTherapeutics

PLUXEE N.V. (PLX) Gets a Sell from Goldman Sachs

Protalix BioTherapeutics Showcases Pipeline Advancements and Innovations in Rare Disease Therapies

Protalix BioTherapeutics Shares Up After CHMP Issued Positive Opinion on New Dosing Regimen for Fabry Disease Treatment

Protalix Fabry Disease Treatment Recommended for Approval by EMA Committee

MT Newswires Live

CHMP Recommends Approval of New Elfabrio Dosing Regimen for Protalix BioTherapeutics

PLUXEE N.V. (PLX) Receives a Buy from Kepler Capital

Protalix BioTherapeutics Projects Profitable Growth Anchored by Elfabrio Sales in 2026

Protalix BioTherapeutics CEO Dror Bashan Acquires Common Shares

Protalix BioTherapeutics and Secarna Pharmaceuticals partner to develop rare kidney disease therapies

Protalix BioTherapeutics Is Maintained at Buy by HC Wainwright & Co.

Protalix price target lowered to $12 from $15 at H.C. Wainwright

Protalix BioTherapeutics Q3 EPS USD 0.03

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PLX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLX\",,,,,undefined,":{"symbol":"PLX","market":"US","secType":"STK","nameCN":"Protalix BioTherapeutics","latestPrice":2.042,"timestamp":1774369520467,"preClose":2.13,"halted":0,"volume":355231,"delay":0,"changeRate":-0.04131455399061037,"floatShares":60755281,"shares":80421181,"eps":-0.08196432,"marketStatus":"Trading","change":-0.088,"latestTime":"03-24 12:25:27 EDT","open":2.13,"high":2.14,"low":2.04,"amount":741382.9758257,"amplitude":0.046948,"askPrice":2.05,"askSize":1332,"bidPrice":2.04,"bidSize":780,"shortable":3,"etf":0,"ttmEps":-0.08196432,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":829022400000,"exchange":"AMEX","adjPreClose":2.13,"preHourTrading":{"tag":"盘前","latestPrice":2.18,"preClose":2.13,"latestTime":"09:25 EDT","volume":2002,"amount":4340.860524,"timestamp":1774358755053,"change":0.05,"changeRate":0.023474,"amplitude":0.011033},"postHourTrading":{"tag":"盘后","latestPrice":2.13,"preClose":2.13,"latestTime":"18:58 EDT","volume":12403,"amount":26407.49,"timestamp":1774306724894,"change":0,"changeRate":0,"amplitude":0.004695},"volumeRatio":0.498147,"impliedVol":0.4258,"impliedVolPercentile":0.2311},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLX\",,,,,undefined,":{"symbol":"PLX","floatShares":60755281,"roa":"-4.41%","roe":"-14.44%","lyrEps":-0.084077,"volumeRatio":0.498147,"shares":80421181,"dividePrice":0,"high":2.14,"amplitude":0.046948,"preClose":2.13,"low":2.04,"week52Low":1.32,"pbRate":"3.40","psRate":"3.11","week52High":3.19,"institutionHeld":0.3271,"latestPrice":2.042,"committee":-0.261364,"eps":-0.08196432,"divideRate":0,"volume":355231,"delay":0,"ttmEps":-0.08196432,"open":2.13,"prevYearClose":1.8,"prevWeekClose":2.14,"prevMonthClose":2.88,"prevQuarterClose":1.8,"fiveDayClose":2.79,"twentyDayClose":3,"sixtyDayClose":1.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-18","symbol":"PLX","fiscalQuarterEnding":"2025/12","expectedEps":0.01,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1773806400000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-11-13","symbol":"PLX","fiscalQuarterEnding":"2025/09","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2025-08-14","symbol":"PLX","fiscalQuarterEnding":"2025/06","expectedEps":0.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2025-05-09","symbol":"PLX","fiscalQuarterEnding":"2025/03","expectedEps":0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-03-17","symbol":"PLX","fiscalQuarterEnding":"2024/12","expectedEps":0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1738814400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLX","date":"2026-03-23","current":-25.803911,"percent":0.022783,"low":-43.274752,"twenty":-6.909674,"median":-2.122315,"eighty":19.694785,"high":81.705333,"avg":5.367022,"sd":19.578674,"marketCap":172423313},"quantilePoints":[{"date":"2021-03-26","current":-33.066688,"twenty":-5.93244,"median":-2.159816,"eighty":-1.286168,"marketCap":219199073},{"date":"2021-04-01","current":-31.238527,"twenty":-6.011792,"median":-2.159816,"eighty":-1.286168,"marketCap":203768911},{"date":"2021-04-09","current":-36.595691,"twenty":-6.161232,"median":-2.158792,"eighty":-1.286095,"marketCap":238713691},{"date":"2021-04-16","current":-43.135605,"twenty":-6.301781,"median":-2.158792,"eighty":-1.286095,"marketCap":281373552},{"date":"2021-04-23","current":-43.274752,"twenty":-6.484124,"median":-2.158792,"eighty":-1.286095,"marketCap":282281208},{"date":"2021-04-30","current":-23.307141,"twenty":-6.640471,"median":-2.159816,"eighty":-1.286168,"marketCap":152032483},{"date":"2021-05-07","current":-21.150361,"twenty":-6.746429,"median":-2.159816,"eighty":-1.286168,"marketCap":137963806},{"date":"2021-05-14","current":-9.099814,"twenty":-6.956439,"median":-2.159816,"eighty":-1.286168,"marketCap":124348956},{"date":"2021-05-21","current":-9.664401,"twenty":-7.610873,"median":-2.159816,"eighty":-1.286168,"marketCap":132064038},{"date":"2021-05-28","current":-10.096144,"twenty":-9.073245,"median":-2.159816,"eighty":-1.286168,"marketCap":137963806},{"date":"2021-06-04","current":-7.107154,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":97119258},{"date":"2021-06-11","current":-7.206787,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":98480743},{"date":"2021-06-18","current":-6.6422,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":90765662},{"date":"2021-06-25","current":-6.608989,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":90311833},{"date":"2021-07-02","current":-5.97798,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":81689095},{"date":"2021-07-09","current":-5.745503,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":78512297},{"date":"2021-07-16","current":-5.247338,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":71704872},{"date":"2021-07-23","current":-5.214127,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":71251044},{"date":"2021-07-30","current":-5.014861,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":68528074},{"date":"2021-08-06","current":-4.98165,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":68074246},{"date":"2021-08-13","current":-4.450274,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":60812993},{"date":"2021-08-20","current":-2.941121,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":61045906},{"date":"2021-08-27","current":-3.511786,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":72890635},{"date":"2021-09-03","current":-3.533735,"twenty":-9.093172,"median":-2.165862,"eighty":-1.286241,"marketCap":73346201},{"date":"2021-09-10","current":-3.2923,"twenty":-9.093172,"median":-2.168414,"eighty":-1.286241,"marketCap":68334970},{"date":"2021-09-17","current":-3.072813,"twenty":-9.093172,"median":-2.169861,"eighty":-1.286241,"marketCap":63779305},{"date":"2021-09-24","current":-2.875275,"twenty":-9.093172,"median":-2.173457,"eighty":-1.286241,"marketCap":59679207},{"date":"2021-10-01","current":-2.743583,"twenty":-9.093172,"median":-2.185224,"eighty":-1.286241,"marketCap":56945808},{"date":"2021-10-08","current":-2.919172,"twenty":-9.08653,"median":-2.194729,"eighty":-1.286241,"marketCap":60590340},{"date":"2021-10-15","current":-2.699686,"twenty":-9.08653,"median":-2.198569,"eighty":-1.286241,"marketCap":56034675},{"date":"2021-10-22","current":-2.546045,"twenty":-9.08653,"median":-2.208245,"eighty":-1.286241,"marketCap":52845710},{"date":"2021-10-29","current":-2.480199,"twenty":-9.08653,"median":-2.213276,"eighty":-1.286241,"marketCap":51479011},{"date":"2021-11-05","current":-2.436302,"twenty":-9.08653,"median":-2.224699,"eighty":-1.286241,"marketCap":50567878},{"date":"2021-11-12","current":-2.502148,"twenty":-9.08653,"median":-2.237881,"eighty":-1.286241,"marketCap":51934577},{"date":"2021-11-19","current":-2.175919,"twenty":-9.08653,"median":-2.240695,"eighty":-1.286241,"marketCap":44645514},{"date":"2021-11-26","current":-2.198123,"twenty":-9.08653,"median":-2.240695,"eighty":-1.286241,"marketCap":45101080},{"date":"2021-12-03","current":-1.806013,"twenty":-9.08653,"median":-2.233869,"eighty":-1.286241,"marketCap":37055776},{"date":"2021-12-10","current":-2.038925,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":41834668},{"date":"2021-12-17","current":-1.940121,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":39807398},{"date":"2021-12-23","current":-2.10931,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":43278814},{"date":"2021-12-31","current":-1.846645,"twenty":-9.079887,"median":-2.228368,"eighty":-1.286241,"marketCap":37889463},{"date":"2022-01-07","current":-1.90948,"twenty":-9.073245,"median":-2.222793,"eighty":-1.286241,"marketCap":39178716},{"date":"2022-01-14","current":-1.909036,"twenty":-9.073245,"median":-2.219151,"eighty":-1.286241,"marketCap":39169605},{"date":"2022-01-21","current":-1.809011,"twenty":-9.073245,"median":-2.213239,"eighty":-1.286241,"marketCap":37117278},{"date":"2022-01-28","current":-1.800151,"twenty":-9.073245,"median":-2.199659,"eighty":-1.286241,"marketCap":36935507},{"date":"2022-02-04","current":-2.286936,"twenty":-9.073245,"median":-2.19473,"eighty":-1.286241,"marketCap":46923346},{"date":"2022-02-11","current":-2.053801,"twenty":-9.073245,"median":-2.192317,"eighty":-1.286241,"marketCap":42139898},{"date":"2022-02-18","current":-1.900155,"twenty":-9.073245,"median":-2.182859,"eighty":-1.286241,"marketCap":38987378},{"date":"2022-02-25","current":-1.845979,"twenty":-9.073245,"median":-2.171729,"eighty":-1.286241,"marketCap":37875796},{"date":"2022-03-04","current":-1.953887,"twenty":-9.073245,"median":-2.164775,"eighty":-1.286241,"marketCap":40089849},{"date":"2022-03-11","current":-1.931683,"twenty":-9.073245,"median":-2.149114,"eighty":-1.286241,"marketCap":39634282},{"date":"2022-03-18","current":-2.331342,"twenty":-9.073245,"median":-2.134081,"eighty":-1.286241,"marketCap":47834479},{"date":"2022-03-25","current":-2.58668,"twenty":-9.073245,"median":-2.134081,"eighty":-1.286241,"marketCap":53073493},{"date":"2022-04-01","current":-1.763177,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":48631935},{"date":"2022-04-08","current":-2.518824,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":69474193},{"date":"2022-04-14","current":-2.199773,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":60674128},{"date":"2022-04-22","current":-2.000411,"twenty":-9.073245,"median":-2.122964,"eighty":-1.286241,"marketCap":55175340},{"date":"2022-04-29","current":-1.950023,"twenty":-9.073245,"median":-2.109577,"eighty":-1.286241,"marketCap":53785525},{"date":"2022-05-06","current":-1.907996,"twenty":-9.073245,"median":-2.106167,"eighty":-1.286241,"marketCap":52626354},{"date":"2022-05-13","current":-1.781917,"twenty":-9.073245,"median":-2.101634,"eighty":-1.296523,"marketCap":49148841},{"date":"2022-05-20","current":-2.19949,"twenty":-9.073245,"median":-2.104124,"eighty":-1.305734,"marketCap":53652162},{"date":"2022-05-27","current":-2.19949,"twenty":-9.073245,"median":-2.108744,"eighty":-1.316067,"marketCap":53652162},{"date":"2022-06-03","current":-2.392428,"twenty":-9.073245,"median":-2.111908,"eighty":-1.325755,"marketCap":58358492},{"date":"2022-06-10","current":-2.160903,"twenty":-9.073245,"median":-2.122315,"eighty":-1.336668,"marketCap":52710896},{"date":"2022-06-17","current":-2.103021,"twenty":-9.073245,"median":-2.122315,"eighty":-1.340638,"marketCap":51298997},{"date":"2022-06-24","current":-2.103021,"twenty":-9.079887,"median":-2.122315,"eighty":-1.345105,"marketCap":51298997},{"date":"2022-07-01","current":-2.093374,"twenty":-9.079887,"median":-2.123693,"eighty":-1.358968,"marketCap":51063680},{"date":"2022-07-08","current":-2.141609,"twenty":-9.079887,"median":-2.128772,"eighty":-1.362564,"marketCap":52240263},{"date":"2022-07-15","current":-2.083727,"twenty":-9.079887,"median":-2.129233,"eighty":-1.365604,"marketCap":50828364},{"date":"2022-07-22","current":-2.04514,"twenty":-9.079887,"median":-2.129233,"eighty":-1.382433,"marketCap":49887098},{"date":"2022-07-29","current":-2.04514,"twenty":-9.079887,"median":-2.129233,"eighty":-1.400792,"marketCap":49887098},{"date":"2022-08-05","current":-2.122315,"twenty":-9.079887,"median":-2.129233,"eighty":-1.416087,"marketCap":51769630},{"date":"2022-08-12","current":-2.363487,"twenty":-9.079887,"median":-2.141609,"eighty":-1.428705,"marketCap":57652542},{"date":"2022-08-19","current":-3.229692,"twenty":-9.079887,"median":-2.151454,"eighty":-1.454072,"marketCap":59704090},{"date":"2022-08-26","current":-3.175864,"twenty":-9.079887,"median":-2.160903,"eighty":-1.46638,"marketCap":58709022},{"date":"2022-09-02","current":-2.933637,"twenty":-9.079887,"median":-2.168513,"eighty":-1.513357,"marketCap":54231215},{"date":"2022-09-09","current":-2.866352,"twenty":-9.079887,"median":-2.173457,"eighty":-1.552879,"marketCap":52987380},{"date":"2022-09-16","current":-3.068208,"twenty":-9.079887,"median":-2.185224,"eighty":-1.597561,"marketCap":56718886},{"date":"2022-09-23","current":-2.772152,"twenty":-9.079887,"median":-2.19473,"eighty":-1.642895,"marketCap":51246011},{"date":"2022-09-30","current":-2.802835,"twenty":-9.079887,"median":-2.19949,"eighty":-1.691667,"marketCap":51813200},{"date":"2022-10-07","current":-2.799067,"twenty":-9.079887,"median":-2.205652,"eighty":-1.708303,"marketCap":51743545},{"date":"2022-10-14","current":-2.745238,"twenty":-9.079887,"median":-2.213275,"eighty":-1.720523,"marketCap":50748477},{"date":"2022-10-21","current":-2.772152,"twenty":-9.079887,"median":-2.225261,"eighty":-1.725838,"marketCap":51246011},{"date":"2022-10-28","current":-2.772152,"twenty":-9.079887,"median":-2.240109,"eighty":-1.732273,"marketCap":51246011},{"date":"2022-11-04","current":-2.718324,"twenty":-9.079887,"median":-2.242805,"eighty":-1.755663,"marketCap":50250943},{"date":"2022-11-11","current":-2.825981,"twenty":-9.079887,"median":-2.250369,"eighty":-1.765675,"marketCap":52241079},{"date":"2022-11-18","current":-3.036417,"twenty":-9.079887,"median":-2.262195,"eighty":-1.778799,"marketCap":54212189},{"date":"2022-11-25","current":-3.391139,"twenty":-9.079887,"median":-2.26358,"eighty":-1.789218,"marketCap":60545389},{"date":"2022-12-02","current":-3.206683,"twenty":-9.079887,"median":-2.278354,"eighty":-1.795365,"marketCap":57252125},{"date":"2022-12-09","current":-3.320194,"twenty":-9.079887,"median":-2.292748,"eighty":-1.799662,"marketCap":59278749},{"date":"2022-12-16","current":-3.291817,"twenty":-9.079887,"median":-2.300018,"eighty":-1.807377,"marketCap":58772093},{"date":"2022-12-23","current":-3.348572,"twenty":-9.079887,"median":-2.308362,"eighty":-1.815181,"marketCap":59785405},{"date":"2022-12-30","current":-3.887749,"twenty":-9.079887,"median":-2.330304,"eighty":-1.816065,"marketCap":69411869},{"date":"2023-01-06","current":-4.341793,"twenty":-9.079887,"median":-2.331425,"eighty":-1.819992,"marketCap":77518364},{"date":"2023-01-13","current":-4.597192,"twenty":-9.079887,"median":-2.347715,"eighty":-1.827125,"marketCap":82078268},{"date":"2023-01-20","current":-4.739081,"twenty":-9.079887,"median":-2.35453,"eighty":-1.836965,"marketCap":84611548},{"date":"2023-01-27","current":-4.455303,"twenty":-9.079887,"median":-2.366765,"eighty":-1.846672,"marketCap":79544988},{"date":"2023-02-03","current":-4.597192,"twenty":-9.079887,"median":-2.372929,"eighty":-1.855292,"marketCap":82078268},{"date":"2023-02-10","current":-4.483681,"twenty":-9.079887,"median":-2.377975,"eighty":-1.863262,"marketCap":80051644},{"date":"2023-02-17","current":-4.426926,"twenty":-9.079887,"median":-2.386937,"eighty":-1.865474,"marketCap":79038332},{"date":"2023-02-24","current":-5.164747,"twenty":-9.079887,"median":-2.395361,"eighty":-1.8693,"marketCap":92211388},{"date":"2023-03-03","current":-7.880419,"twenty":-9.079887,"median":-2.409349,"eighty":-1.87939,"marketCap":117631009},{"date":"2023-03-10","current":-7.111597,"twenty":-9.079887,"median":-2.414353,"eighty":-1.887277,"marketCap":106154813},{"date":"2023-03-17","current":-7.803536,"twenty":-9.079887,"median":-2.420155,"eighty":-1.897474,"marketCap":116483389},{"date":"2023-03-24","current":-7.649772,"twenty":-9.079887,"median":-2.433443,"eighty":-1.901141,"marketCap":114188150},{"date":"2023-03-31","current":-8.072624,"twenty":-9.073245,"median":-2.439918,"eighty":-1.90865,"marketCap":120500058},{"date":"2023-04-06","current":-8.226388,"twenty":-9.073245,"median":-2.446146,"eighty":-1.912148,"marketCap":122795297},{"date":"2023-04-14","current":-9.571826,"twenty":-9.400542,"median":-2.46771,"eighty":-1.922938,"marketCap":142878640},{"date":"2023-04-21","current":-8.956768,"twenty":-9.457132,"median":-2.480199,"eighty":-1.931683,"marketCap":133697683},{"date":"2023-04-28","current":-10.263765,"twenty":-9.567591,"median":-2.502031,"eighty":-1.934828,"marketCap":153207216},{"date":"2023-05-05","current":-14.724601,"twenty":-9.651117,"median":-2.520118,"eighty":-1.939455,"marketCap":219794121},{"date":"2023-05-12","current":-10.576213,"twenty":-10.196717,"median":-2.536056,"eighty":-1.94368,"marketCap":166808038},{"date":"2023-05-19","current":-9.162809,"twenty":-10.196717,"median":-2.545576,"eighty":-1.945022,"marketCap":144515819},{"date":"2023-05-26","current":-8.948724,"twenty":-10.196717,"median":-2.560684,"eighty":-1.945022,"marketCap":141139282},{"date":"2023-06-02","current":-9.162809,"twenty":-10.196717,"median":-2.582062,"eighty":-1.945022,"marketCap":144515819},{"date":"2023-06-09","current":-9.976329,"twenty":-10.332959,"median":-2.61351,"eighty":-1.945022,"marketCap":157346663},{"date":"2023-06-16","current":-9.633794,"twenty":-10.332959,"median":-2.630673,"eighty":-1.945022,"marketCap":151944203},{"date":"2023-06-23","current":-9.505344,"twenty":-10.356023,"median":-2.656774,"eighty":-1.945022,"marketCap":149918280},{"date":"2023-06-30","current":-9.291259,"twenty":-10.379088,"median":-2.691448,"eighty":-1.945022,"marketCap":146541742},{"date":"2023-07-07","current":-7.664219,"twenty":-10.379088,"median":-2.708789,"eighty":-1.945022,"marketCap":120880055},{"date":"2023-07-14","current":-7.664219,"twenty":-10.379088,"median":-2.729688,"eighty":-1.945022,"marketCap":120880055},{"date":"2023-07-21","current":-7.364501,"twenty":-10.379088,"median":-2.745103,"eighty":-1.945022,"marketCap":116152902},{"date":"2023-07-28","current":-7.150416,"twenty":-10.379088,"median":-2.745238,"eighty":-1.945022,"marketCap":112776364},{"date":"2023-08-04","current":-7.364501,"twenty":-10.38417,"median":-2.755336,"eighty":-1.944575,"marketCap":116152902},{"date":"2023-08-11","current":15.199151,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":135287640},{"date":"2023-08-18","current":15.359988,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":136719255},{"date":"2023-08-25","current":16.244595,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":144593139},{"date":"2023-09-01","current":15.199151,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":135287640},{"date":"2023-09-08","current":14.797057,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":131708602},{"date":"2023-09-15","current":13.91245,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":123834718},{"date":"2023-09-22","current":13.349518,"twenty":-10.38417,"median":-2.755336,"eighty":-1.937003,"marketCap":118824064},{"date":"2023-09-29","current":12.947425,"twenty":-10.38417,"median":-2.755336,"eighty":-1.931683,"marketCap":115245026},{"date":"2023-10-06","current":12.867006,"twenty":-10.38417,"median":-2.74793,"eighty":-1.924528,"marketCap":114529219},{"date":"2023-10-13","current":11.982399,"twenty":-10.38417,"median":-2.74793,"eighty":-1.91452,"marketCap":106655335},{"date":"2023-10-20","current":11.741143,"twenty":-10.38417,"median":-2.74793,"eighty":-1.909391,"marketCap":104507912},{"date":"2023-10-27","current":11.982399,"twenty":-10.399416,"median":-2.764616,"eighty":-1.90816,"marketCap":106655335},{"date":"2023-11-03","current":13.590775,"twenty":-10.399416,"median":-2.764616,"eighty":-1.90816,"marketCap":120971487},{"date":"2023-11-10","current":9.551945,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899704,"marketCap":101403452},{"date":"2023-11-17","current":9.551945,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":101403452},{"date":"2023-11-24","current":9.826821,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":104321537},{"date":"2023-12-01","current":10.376574,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":110157707},{"date":"2023-12-08","current":11.682235,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":124018610},{"date":"2023-12-15","current":12.09455,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":128395738},{"date":"2023-12-22","current":11.957111,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":126936695},{"date":"2023-12-29","current":12.369426,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":131313823},{"date":"2024-01-05","current":11.957111,"twenty":-10.404498,"median":-2.770538,"eighty":-1.89955,"marketCap":126936695},{"date":"2024-01-12","current":11.269921,"twenty":-10.404498,"median":-2.770538,"eighty":-1.89955,"marketCap":119641483},{"date":"2024-01-19","current":10.101698,"twenty":-10.438841,"median":-2.771211,"eighty":-1.899583,"marketCap":107239622},{"date":"2024-01-26","current":10.376574,"twenty":-10.404498,"median":-2.770538,"eighty":-1.898048,"marketCap":110157707},{"date":"2024-02-02","current":10.101698,"twenty":-10.404498,"median":-2.770538,"eighty":-1.887499,"marketCap":107239622},{"date":"2024-02-09","current":10.307855,"twenty":-10.404498,"median":-2.770538,"eighty":-1.878194,"marketCap":109428186},{"date":"2024-02-16","current":10.445293,"twenty":-10.404498,"median":-2.770538,"eighty":-1.865074,"marketCap":110887228},{"date":"2024-02-23","current":9.826821,"twenty":-10.404498,"median":-2.770538,"eighty":-1.859242,"marketCap":104321537},{"date":"2024-03-01","current":11.201202,"twenty":-10.399416,"median":-2.764616,"eighty":-1.84065,"marketCap":118911962},{"date":"2024-03-08","current":10.032979,"twenty":-10.399416,"median":-2.764616,"eighty":-1.815126,"marketCap":106510101},{"date":"2024-03-15","current":12.024111,"twenty":-10.399416,"median":-2.764616,"eighty":-1.798801,"marketCap":99944409},{"date":"2024-03-22","current":11.601155,"twenty":-10.399416,"median":-2.753312,"eighty":-1.765715,"marketCap":96428803},{"date":"2024-03-28","current":10.985943,"twenty":-10.399416,"median":-2.753312,"eighty":-1.731141,"marketCap":91315155},{"date":"2024-04-05","current":10.634392,"twenty":-10.404498,"median":-2.758695,"eighty":-1.704982,"marketCap":88393070},{"date":"2024-04-12","current":10.72228,"twenty":-10.404498,"median":-2.758695,"eighty":-1.630901,"marketCap":89123591},{"date":"2024-04-19","current":9.931292,"twenty":-10.404498,"median":-2.758695,"eighty":-1.553621,"marketCap":82548900},{"date":"2024-04-26","current":10.37073,"twenty":-10.399416,"median":-2.753312,"eighty":-1.502768,"marketCap":86201506},{"date":"2024-05-03","current":10.231792,"twenty":-10.399416,"median":-2.753312,"eighty":-1.45681,"marketCap":85046657},{"date":"2024-05-10","current":11.025638,"twenty":-10.399416,"median":-2.753312,"eighty":-1.426977,"marketCap":91645105},{"date":"2024-05-17","current":12.526258,"twenty":-10.399416,"median":-2.753312,"eighty":-1.393687,"marketCap":85779818},{"date":"2024-05-24","current":12.633321,"twenty":-10.399416,"median":-2.753312,"eighty":-1.35988,"marketCap":86512979},{"date":"2024-05-31","current":12.205072,"twenty":-10.399416,"median":-2.753312,"eighty":-1.337474,"marketCap":83580335},{"date":"2024-06-07","current":12.09801,"twenty":-10.399416,"median":-2.746584,"eighty":-1.32008,"marketCap":82847174},{"date":"2024-06-14","current":12.419196,"twenty":-10.404498,"median":-2.745238,"eighty":-1.307985,"marketCap":85046657},{"date":"2024-06-21","current":12.526258,"twenty":-10.438841,"median":-2.746584,"eighty":-1.281516,"marketCap":85779818},{"date":"2024-06-28","current":13.811003,"twenty":-10.54187,"median":-2.758695,"eighty":-1.257877,"marketCap":94577748},{"date":"2024-07-05","current":11.134452,"twenty":-10.54187,"median":-2.758695,"eighty":-1.2431,"marketCap":76248727},{"date":"2024-07-12","current":12.205072,"twenty":-10.54187,"median":-2.758695,"eighty":-1.222499,"marketCap":83580335},{"date":"2024-07-15","current":12.205072,"twenty":-10.54187,"median":-2.758695,"eighty":-1.212089,"marketCap":83580335},{"date":"2024-08-02","current":11.348576,"twenty":-11.649165,"median":-2.772152,"eighty":-1.193601,"marketCap":77715049},{"date":"2024-08-09","current":11.134452,"twenty":-11.649165,"median":-2.772152,"eighty":-1.178742,"marketCap":76248727},{"date":"2024-08-16","current":-4.754699,"twenty":-11.649165,"median":-2.772152,"eighty":-1.164919,"marketCap":69865540},{"date":"2024-08-23","current":-4.697142,"twenty":-11.649165,"median":-2.793651,"eighty":-1.164919,"marketCap":69019799},{"date":"2024-08-30","current":-4.555001,"twenty":-11.649165,"median":-2.799067,"eighty":-1.164919,"marketCap":66931187},{"date":"2024-09-06","current":-5.105045,"twenty":-11.649165,"median":-2.825981,"eighty":-1.172176,"marketCap":75013527},{"date":"2024-09-13","current":-5.305243,"twenty":-11.649165,"median":-2.832709,"eighty":-1.172176,"marketCap":77955234},{"date":"2024-09-20","current":-5.755688,"twenty":-11.649165,"median":-2.864199,"eighty":-1.172176,"marketCap":84574075},{"date":"2024-09-27","current":-5.355292,"twenty":-11.649165,"median":-2.877542,"eighty":-1.183349,"marketCap":78690661},{"date":"2024-10-04","current":-5.054995,"twenty":-11.649165,"median":-2.919172,"eighty":-1.235399,"marketCap":74278100},{"date":"2024-10-11","current":-5.004946,"twenty":-11.649165,"median":-2.926909,"eighty":-1.318237,"marketCap":73542674},{"date":"2024-10-18","current":-5.455391,"twenty":-11.649165,"median":-2.961811,"eighty":-1.343261,"marketCap":80161514},{"date":"2024-10-25","current":-5.155094,"twenty":-11.649165,"median":-3.006085,"eighty":-1.359997,"marketCap":75748954},{"date":"2024-10-31","current":-5.855787,"twenty":-11.649165,"median":-3.008039,"eighty":-1.398056,"marketCap":86044928},{"date":"2024-11-08","current":-5.805737,"twenty":-11.689082,"median":-3.036417,"eighty":-1.525183,"marketCap":85309501},{"date":"2024-11-15","current":-7.056974,"twenty":-11.689082,"median":-3.072813,"eighty":-1.58483,"marketCap":103695170},{"date":"2024-11-22","current":-12.724521,"twenty":-11.98416,"median":-3.14895,"eighty":-1.643965,"marketCap":122231747},{"date":"2024-11-29","current":-13.184443,"twenty":-12.17163,"median":-3.149928,"eighty":-1.708859,"marketCap":126649762},{"date":"2024-12-06","current":-12.49456,"twenty":-12.366043,"median":-3.229692,"eighty":-1.708859,"marketCap":120022740},{"date":"2024-12-13","current":-13.797673,"twenty":-12.463249,"median":-3.291817,"eighty":-1.71628,"marketCap":132540449},{"date":"2024-12-20","current":-13.337751,"twenty":-12.497966,"median":-3.310435,"eighty":-1.73821,"marketCap":128122434},{"date":"2024-12-27","current":-13.644366,"twenty":-12.532682,"median":-3.320194,"eighty":-1.780748,"marketCap":131067777},{"date":"2025-01-03","current":-15.100787,"twenty":-12.605949,"median":-3.348572,"eighty":-1.788536,"marketCap":145058158},{"date":"2025-01-10","current":-17.400399,"twenty":-12.708302,"median":-3.419516,"eighty":-1.785226,"marketCap":167148233},{"date":"2025-01-17","current":-16.633862,"twenty":-12.808567,"median":-3.52276,"eighty":-1.785226,"marketCap":159784875},{"date":"2025-01-24","current":-19.393396,"twenty":-12.953442,"median":-3.648888,"eighty":-1.785226,"marketCap":186292964},{"date":"2025-01-31","current":-18.24359,"twenty":-13.053431,"median":-3.807696,"eighty":-1.785226,"marketCap":175247927},{"date":"2025-02-07","current":-20.619856,"twenty":-13.179071,"median":-3.887749,"eighty":-1.785226,"marketCap":198074338},{"date":"2025-02-14","current":-20.389895,"twenty":-13.360254,"median":-4.058015,"eighty":-1.785226,"marketCap":195865330},{"date":"2025-02-21","current":-18.626859,"twenty":-13.491058,"median":-4.162726,"eighty":-1.785226,"marketCap":178929606},{"date":"2025-02-28","current":-17.860321,"twenty":-13.571831,"median":-4.258509,"eighty":-1.785226,"marketCap":171566248},{"date":"2025-03-07","current":-18.166936,"twenty":-13.797673,"median":-4.37017,"eighty":-1.781917,"marketCap":174511591},{"date":"2025-03-14","current":-16.633862,"twenty":-14.027634,"median":-4.426926,"eighty":-1.806013,"marketCap":159784875},{"date":"2025-03-21","current":62.809311,"twenty":-14.199078,"median":-4.426926,"eighty":-1.781917,"marketCap":184156900},{"date":"2025-03-28","current":68.664416,"twenty":-14.199078,"median":-4.426926,"eighty":-1.731486,"marketCap":201324069},{"date":"2025-04-04","current":69.196699,"twenty":-14.199078,"median":-4.426926,"eighty":9.414507,"marketCap":202884721},{"date":"2025-04-11","current":61.478605,"twenty":-14.164789,"median":-4.426926,"eighty":9.60692,"marketCap":180255271},{"date":"2025-04-17","current":69.196699,"twenty":-14.164789,"median":-4.37017,"eighty":9.758102,"marketCap":202884721},{"date":"2025-04-25","current":78.245498,"twenty":-14.199078,"median":-4.058015,"eighty":9.826821,"marketCap":229415799},{"date":"2025-05-02","current":79.842345,"twenty":-14.199078,"median":-3.731273,"eighty":9.895541,"marketCap":234097755},{"date":"2025-05-09","current":76.914792,"twenty":-14.199078,"median":-3.62153,"eighty":10.01918,"marketCap":225514170},{"date":"2025-05-16","current":34.018394,"twenty":-14.199078,"median":-3.44594,"eighty":10.055382,"marketCap":132943882},{"date":"2025-05-23","current":33.610987,"twenty":-14.199078,"median":-3.37695,"eighty":10.101698,"marketCap":131351739},{"date":"2025-05-30","current":32.38877,"twenty":-14.199078,"median":-3.34545,"eighty":10.107067,"marketCap":126575312},{"date":"2025-06-06","current":30.962849,"twenty":-14.199078,"median":-3.320194,"eighty":10.170417,"marketCap":121002814},{"date":"2025-06-13","current":31.370255,"twenty":-14.199078,"median":-3.291817,"eighty":10.239136,"marketCap":122594957},{"date":"2025-06-20","current":28.518414,"twenty":-14.027634,"median":-3.241732,"eighty":10.37073,"marketCap":111449961},{"date":"2025-06-27","current":29.536928,"twenty":-13.848978,"median":-3.190184,"eighty":10.376574,"marketCap":115430316},{"date":"2025-07-03","current":31.370255,"twenty":-13.848978,"median":-3.149439,"eighty":10.459037,"marketCap":122594957},{"date":"2025-07-11","current":30.148037,"twenty":-13.848978,"median":-3.108336,"eighty":10.583107,"marketCap":117818530},{"date":"2025-07-18","current":30.555443,"twenty":-13.848978,"median":-3.054751,"eighty":10.65145,"marketCap":119410672},{"date":"2025-07-25","current":31.573958,"twenty":-13.848978,"median":-3.021648,"eighty":10.720591,"marketCap":123391028},{"date":"2025-08-01","current":29.740631,"twenty":-13.848978,"median":-3.006967,"eighty":10.793764,"marketCap":116226387},{"date":"2025-08-08","current":30.759146,"twenty":-13.848978,"median":-2.971366,"eighty":10.903709,"marketCap":120206743},{"date":"2025-08-15","current":19.313596,"twenty":-13.644366,"median":-2.937379,"eighty":11.065777,"marketCap":121192814},{"date":"2025-08-22","current":20.075975,"twenty":-13.429736,"median":-2.919172,"eighty":11.134452,"marketCap":125976741},{"date":"2025-08-29","current":19.694785,"twenty":-13.123121,"median":-2.8825,"eighty":11.169615,"marketCap":123584778},{"date":"2025-09-05","current":20.203038,"twenty":-12.90849,"median":-2.875275,"eighty":11.241514,"marketCap":126774062},{"date":"2025-09-12","current":22.108985,"twenty":-12.628566,"median":-2.846166,"eighty":11.42538,"marketCap":138733880},{"date":"2025-09-19","current":23.633742,"twenty":-12.250828,"median":-2.825981,"eighty":11.601155,"marketCap":148301733},{"date":"2025-09-26","current":25.920879,"twenty":-10.604625,"median":-2.799067,"eighty":11.743105,"marketCap":162653514},{"date":"2025-10-03","current":29.732773,"twenty":-10.114998,"median":-2.793273,"eighty":11.832516,"marketCap":186573149},{"date":"2025-10-10","current":32.528162,"twenty":-9.805062,"median":-2.772152,"eighty":11.957111,"marketCap":204114214},{"date":"2025-10-17","current":30.495152,"twenty":-9.762245,"median":-2.772018,"eighty":11.990948,"marketCap":191357076},{"date":"2025-10-24","current":29.351583,"twenty":-9.666843,"median":-2.745238,"eighty":12.062818,"marketCap":184181185},{"date":"2025-10-31","current":28.716268,"twenty":-9.575656,"median":-2.745238,"eighty":12.09801,"marketCap":180194579},{"date":"2025-11-07","current":28.208015,"twenty":-9.495624,"median":-2.743583,"eighty":12.205072,"marketCap":177005295},{"date":"2025-11-14","current":24.73512,"twenty":-9.387308,"median":-2.699686,"eighty":12.300707,"marketCap":155212879},{"date":"2025-11-21","current":25.942316,"twenty":-9.269689,"median":-2.615734,"eighty":12.37938,"marketCap":139932854},{"date":"2025-11-28","current":26.538692,"twenty":-9.163458,"median":-2.567994,"eighty":12.464912,"marketCap":143149702},{"date":"2025-12-05","current":26.09141,"twenty":-9.067701,"median":-2.545381,"eighty":12.526258,"marketCap":140737066},{"date":"2025-12-12","current":27.28416,"twenty":-8.948724,"median":-2.50209,"eighty":12.602031,"marketCap":147170761},{"date":"2025-12-19","current":26.836879,"twenty":-8.571936,"median":-2.480199,"eighty":12.656675,"marketCap":144758125},{"date":"2025-12-26","current":26.389598,"twenty":-8.326335,"median":-2.442358,"eighty":12.851357,"marketCap":142345490},{"date":"2026-01-02","current":26.836879,"twenty":-8.103377,"median":-2.417254,"eighty":13.056001,"marketCap":144758125},{"date":"2026-01-09","current":29.818755,"twenty":-7.958628,"median":-2.392428,"eighty":13.349518,"marketCap":160842362},{"date":"2026-01-16","current":30.713317,"twenty":-7.818489,"median":-2.365591,"eighty":13.606859,"marketCap":165667632},{"date":"2026-01-23","current":31.160598,"twenty":-7.77061,"median":-2.332944,"eighty":13.811003,"marketCap":168080268},{"date":"2026-01-30","current":30.862411,"twenty":-7.691977,"median":-2.280199,"eighty":14.105455,"marketCap":166471844},{"date":"2026-02-06","current":43.386288,"twenty":-7.664219,"median":-2.244114,"eighty":14.877476,"marketCap":234025636},{"date":"2026-02-13","current":42.640819,"twenty":-7.611331,"median":-2.19949,"eighty":15.295653,"marketCap":230004577},{"date":"2026-02-20","current":46.964538,"twenty":-7.442925,"median":-2.182913,"eighty":15.440407,"marketCap":253326720},{"date":"2026-02-27","current":44.877225,"twenty":-7.195944,"median":-2.160903,"eighty":15.617329,"marketCap":242067754},{"date":"2026-03-06","current":41.448069,"twenty":-7.108399,"median":-2.136786,"eighty":16.019423,"marketCap":223570883},{"date":"2026-03-13","current":41.597162,"twenty":-6.991466,"median":-2.122315,"eighty":19.466072,"marketCap":224375094},{"date":"2026-03-20","current":-27.20696,"twenty":-6.909674,"median":-2.122315,"eighty":19.694785,"marketCap":179674761},{"date":"2026-03-23","current":-26.108921,"twenty":-6.909674,"median":-2.122315,"eighty":19.694785,"marketCap":172423313}],"updateTime":1774359946672},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620743240","title":"Protalix BioTherapeutics Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2620743240","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620743240?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:25","pubTimestamp":1773923100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2026 08:25 ET (12:25 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX"],"gpt_icon":0},{"id":"2620266667","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2620266667","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620266667?lang=en_us&edition=fundamental","pubTime":"2026-03-19 02:03","pubTimestamp":1773856986,"startTime":"0","endTime":"0","summary":"GSI Technology  said Wednesday its board has completed s strategic alternatives review and decided to continue operating as a standalone company.Shares were down 25% intraday, with trading volume of over 2.8 million shares versus a daily average of roughly 1.6 million.Cibus  reported a wider-than-expected Q4 net loss late Tuesday and a decrease in quarterly revenue.Shares slid nearly 21% as intraday trading volume jumped to over 750,000 from a daily average of about 435,000.Protalix BioTherapeutics  swung to a full-year EPS loss and reported a decrease in revenue.Shares fell about 19%, with intraday trading volume of over 2.9 million shares versus a daily average of roughly 1.2 million.Price: 6.35, Change: -2.14, Percent Change: -25.22","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBUS","PLX","BK4139","BK4141","GSIT"],"gpt_icon":0},{"id":"2620230442","title":"Protalix Biotherapeutics Reports Fiscal Year 2025 Financial And Business Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620230442","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620230442?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:31","pubTimestamp":1773833461,"startTime":"0","endTime":"0","summary":"March 18 (Reuters) - Protalix Biotherapeutics Inc ::*PROTALIX BIOTHERAPEUTICS REPORTS FISCAL YEAR 2025 FINANCIAL AND BUSINESS RESULTS*PROTALIX BIOTHERAPEUTICS INC: EXPECTS TOTAL REVENUES IN 2026 TO RA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nRSD2Lg5dp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2620232200","title":"Protalix BioTherapeutics FY 2025 R&D expenses rose 51% to USD 19.57 million as net loss totaled USD 6.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620232200","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620232200?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:50","pubTimestamp":1773831033,"startTime":"0","endTime":"0","summary":"Protalix published a press release with full-year fiscal 2025 financial and business results. Revenues from selling goods were USD 51.8 million, down 2%, driven mainly by lower sales to Chiesi due to a change in average net selling price and inventory quantities. R&D expenses were USD 19.6 million, up 51%, primarily due to preparations for the RELEASE Phase 2 study of PRX-115. Net loss was USD 6.6 million, and cash, cash equivalents and short-term bank deposits were USD 30.3 million. The company said the European Commission approved a 2mg/kg every-4-weeks dosing regimen for Elfabrio in adults with Fabry disease, triggering entitlement to a USD 25 million milestone payment from Chiesi, and it forecast 2026 total revenue of USD 78 million to USD 83 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL7wgwjZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2620232751","title":"Press Release: Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620232751","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620232751?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:50","pubTimestamp":1773831000,"startTime":"0","endTime":"0","summary":"Company to host conference call and webcast today at 8:00 a.m. EDT. -- The European Commission  approved the 2mg/kg every-4-weeks . dosing regimen for Elfabrio in adults living with Fabry disease. providing a meaningful reduction in treatment burden without compromising. -- The EC approval triggered the Company's entitlement to a $25.0 million. milestone payment from Chiesi, strengthening the Company's cash position. and supporting an expected cash balance of approximately $50.0 million by. -- Based on current estimates, management expects total revenues in 2026 to. range from approximately $78.0 million to $83.0 million including the. -- The Phase 2 clinical trial of PRX--115 is actively enrolling; the Company. believes PRX-115 has the potential to be a best-in-class therapy,-- Continued strategic focus on rare renal diseases to build a pipeline","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4087","IE00BLSP4452.SGD","BK4232","SGXZ57979304.SGD","BK4585","SG9999011175.SGD","LU0868494617.USD","BK4581","LU0225771236.USD","LU1066051498.USD","LU1894683264.USD","SG9999001176.SGD","BK4139","BK4007","PFE","BK4550","BK4201","SG9999013999.USD","LU0321505868.SGD","EC","IE00B19Z3B42.SGD","LU0122379950.USD","LU1883839398.USD","LU0306806265.USD","BK4534","BK4588","R","LU0170899867.USD","LU0234572021.USD","BK4599","IE00BLSP4239.USD","LU0058720904.USD","LU0306807586.USD","LU1066053197.SGD","IE0002270589.USD","IE00BBT3K403.USD","LU0985481810.HKD","LU1057294990.SGD","CHMP","IE000M9KFDE8.USD","SG9999002224.SGD","SG9999001176.USD","LU0321505439.SGD","SG9999002232.USD","BK4533","LU0225284248.USD","BK4592","LU1894683348.USD","BK4022"],"gpt_icon":0},{"id":"2618256946","title":"Protalix BioTherapeutics to report fiscal 2025 results and host conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2618256946","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618256946?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:50","pubTimestamp":1773226218,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics to report fiscal 2025 results and host conference call               Protalix will release fiscal year 2025 financial results and provide a business update on March 18, 2026. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL5r5dBN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2618283216","title":"EU Approves Four‑week Dosing Option For Chiesi and Protalix’s Elfabrio","url":"https://stock-news.laohu8.com/highlight/detail?id=2618283216","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618283216?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:15","pubTimestamp":1773054908,"startTime":"0","endTime":"0","summary":"March 9 (Reuters) - Protalix Biotherapeutics Inc ::*CHIESI GLOBAL RARE DISEASES AND PROTALIX BIOTHERAPEUTICS ANNOUNCE EUROPEAN COMMISSION APPROVAL OF ADDITIONAL DOSING REGIMEN OF EVERY FOUR WEEKS FOR ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nRSD1fyRhs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2618425296","title":"European Commission approves every-four-weeks Elfabrio dosing regimen for Protalix BioTherapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2618425296","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618425296?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:00","pubTimestamp":1773050433,"startTime":"0","endTime":"0","summary":"The European Commission approved an additional dosing regimen for Chiesi and Protalix’s Elfabrio  in adults with Fabry disease who are stable on enzyme replacement therapy. The regimen is 2 mg/kg every four weeks. Protalix is entitled to a USD 25 million regulatory milestone payment from Chiesi tied to the approval.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL6LpM3n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU2095319765.USD","LU0314104364.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4112","SG9999014021.USD","NDAQ","PLX","IE00B3QW5Z07.USD","BK4139","BK4585","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014005.SGD","LU2210150020.SGD","BK4588","SG9999014039.USD"],"gpt_icon":0},{"id":"2611120348","title":"PLUXEE N.V. (PLX) Gets a Sell from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2611120348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611120348?lang=en_us&edition=fundamental","pubTime":"2026-02-15 23:25","pubTimestamp":1771169118,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Ben Andrews maintained a Sell rating on PLUXEE N.V. on February 12 and set a price target of €11.00. The company’s shares clo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-gets-a-sell-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-gets-a-sell-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1868836914.USD","IE00BFXG1179.USD","LU2237443978.SGD","LU0251131958.USD","LU2471134952.CNY","IE0002270589.USD","GSX","LU2471134796.USD","IE0004091025.USD","LU0048573561.USD","BK4550","IE0034235188.USD","LU1868837300.USD","LU1868836591.USD","BK4585","IE0004086264.USD","IE00B19Z3581.USD","IE00BSNM7G36.USD","BK4552","LU0096364046.USD","LU0251142724.SGD","LU1894683348.USD","LU2237443549.SGD","LU0106831901.USD","LU2237443895.HKD","LU1791807156.HKD","LU2471134523.USD","BK4139","LU2237438978.USD","LU1894683264.USD","LU2750360997.AUD","PLX","BK4516","LU2750360641.GBP","IE00B19Z3B42.SGD","BK4504","LU2237443382.USD","LU2265009873.SGD","LU0742534661.SGD","LU1868837136.USD","LU1804176565.USD","LU0345770993.USD","LU1868836757.USD","LU1668664300.SGD","LU0061475181.USD","LU2237443622.USD","BK4533","LU0345770308.USD","LU2471134879.HKD"],"gpt_icon":0},{"id":"2610596262","title":"Protalix BioTherapeutics Showcases Pipeline Advancements and Innovations in Rare Disease Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2610596262","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610596262?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:28","pubTimestamp":1770848901,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has released a corporate presentation detailing its ongoing developments in rare disease treatments. The company highlighted its two partnered commercial enzyme replacement therapies: Elfabrio, approved in the United States, European Union, and other markets in partnership with Chiesi Global Rare Diseases, and Elelyso, approved in 23 markets through a collaboration with Pfizer and Fiocruz in Brazil. The presentation also outlined the progress of PRX-115, a potential best-in-class therapy for uncontrolled gout, currently enrolling patients in a Phase 2 clinical trial. Protalix emphasized its proprietary ProCellEx platform for plant cell-based protein expression and discussed future pipeline goals targeting rare diseases with a focus on renal indications. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL1N8zRv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU1066053197.SGD","LU0985481810.HKD","LU0122379950.USD","LU0321505439.SGD","LU1066051498.USD","BK4599","LU1883839398.USD","PLX","SGXZ57979304.SGD","LU0321505868.SGD","LU0289739699.SGD","LU0058720904.USD","SG9999001176.SGD","PFE","SG9999002224.SGD","LU1023059063.AUD","BK4534","BK4588","IE00BBT3K403.USD","LU0225771236.USD","BK4581","IE00B19Z3581.USD","SG9999001176.USD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0456855351.SGD","LU0234572021.USD","SG9999002232.USD","LU0306807586.USD","LU0868494617.USD","SG9999013999.USD","BK4550","LU1894683348.USD","BK4007","LU0225284248.USD","BK4585","BK4568","IE0002270589.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","SG9999003800.SGD","BK4533","SG9999011175.SGD","BK4139","IE000M9KFDE8.USD","LU0170899867.USD","LU0306806265.USD","BK4592"],"gpt_icon":0},{"id":"2608893279","title":"Protalix BioTherapeutics Shares Up After CHMP Issued Positive Opinion on New Dosing Regimen for Fabry Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2608893279","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608893279?lang=en_us&edition=fundamental","pubTime":"2026-02-03 00:00","pubTimestamp":1770048000,"startTime":"0","endTime":"0","summary":"Shares of Protalix BioTherapeutics jumped after the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion on a new dosing regimen of its Fabry disease treatment.The stock rose 7.9% to $2.53 in Monday morning trading. The shares have increased 3% in the past year.The biopharmaceutical company focused on rare diseases said Monday that the committee gave a positive opinion of a new dosing regimen of 2 mg per kilogram every four weeks for Protalix's Elfabrio drug.The opinion will be reviewed by the European Commission with a decision anticipated by March. If approved, Elfabrio will be available in two doses, including the already approved regimen of 1 mg per kilogram every two weeks, to patients in the European Union.Protalix, and its collaborator Chiesi Global's rare diseases unit, said the new regimen could reduce the burden to eligible patients and their families by alleviating the current requirement to visit infusion centers every two wee","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","PLX","CHMP","BK4139"],"gpt_icon":0},{"id":"2607047855","title":"Protalix Fabry Disease Treatment Recommended for Approval by EMA Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2607047855","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607047855?lang=en_us&edition=fundamental","pubTime":"2026-01-30 23:32","pubTimestamp":1769787142,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics and Chiesi Global Rare Diseases said Friday that Elfabrio, an enzyme replacement therapy to treat Fabry disease, has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency.Protalix will be eligible to receive a regulatory milestone payment of $25 million if the treatment is approved by the European Commission, the companies said.Protalix shares were more than 7% higher in recent trading.Price: 2.26, Change: +0.18, Percent Change: +8.41","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PLX","EMA","BK4081","BK4139"],"gpt_icon":0},{"id":"2607041098","title":"CHMP Recommends Approval of New Elfabrio Dosing Regimen for Protalix BioTherapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2607041098","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607041098?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:48","pubTimestamp":1769784481,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. and Chiesi Global Rare Diseases announced that the Committee for Medicinal Products for Human Use  of the European Medicines Agency  has issued a positive opinion recommending the approval of a new dosing regimen for Elfabrio  in the European Union. The recommended regimen is 2 mg/kg every four weeks for adult Fabry disease patients who are stable on enzyme replacement therapy. The CHMP's opinion follows a re-examination of the application and will be reviewed by the European Commission, with a decision expected by March 2026. If approved, this regimen would offer an alternative to the current treatment schedule, which requires infusions every two weeks. This dosing regimen is not currently approved in the United States, where the approved regimen remains 1 mg/kg every two weeks.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL2t9FRv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","SG9999014021.USD","BK4139","IE00BKPKM429.USD","BK4112","LU0314104364.USD","SG9999014013.SGD","SG9999014005.SGD","LU2210150020.SGD","LU2095319765.USD","SG9999014039.USD","PLX"],"gpt_icon":0},{"id":"2605426714","title":"PLUXEE N.V. (PLX) Receives a Buy from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605426714","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605426714?lang=en_us&edition=fundamental","pubTime":"2026-01-23 09:51","pubTimestamp":1769133073,"startTime":"0","endTime":"0","summary":"Kepler Capital analyst Julien Richer maintained a Buy rating on PLUXEE N.V. on January 21 and set a price target of €18.00. The company’s shares cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-receives-a-buy-from-kepler-capital-blurbs-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-receives-a-buy-from-kepler-capital-blurbs-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2601885135","title":"Protalix BioTherapeutics Projects Profitable Growth Anchored by Elfabrio Sales in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601885135","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601885135?lang=en_us&edition=fundamental","pubTime":"2026-01-05 19:50","pubTimestamp":1767613816,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. announced that it enters 2026 with a profitable commercial business through its partners and a focused pipeline targeting high unmet medical needs. The company expects future sales to continue being anchored by Elfabrio, marketed by partner Chiesi in the United States and key international markets. Protalix projects that Elfabrio is positioned to capture 15% to 20% of the global Fabry market, which is estimated to reach approximately $3.4 billion by 2030. The company remains committed to advancing its pipeline, including potential therapies for uncontrolled gout and rare renal diseases, while expanding its commercial footprint and pursuing strategic partnerships to accelerate growth and scale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as finan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL6NBN02:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2593904497","title":"Protalix BioTherapeutics CEO Dror Bashan Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593904497","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593904497?lang=en_us&edition=fundamental","pubTime":"2025-12-23 20:26","pubTimestamp":1766492792,"startTime":"0","endTime":"0","summary":"Dror Bashan, President and CEO of Protalix BioTherapeutics Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 23, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL3TypGn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Protalix BioTherapeutics CEO Dror Bashan Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2592994499","title":"Protalix BioTherapeutics and Secarna Pharmaceuticals partner to develop rare kidney disease therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994499","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994499?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:50","pubTimestamp":1765972217,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has announced a collaboration and option agreement with Secarna Pharmaceuticals GmbH & Co. KG to jointly develop novel antisense oligonucleotide  therapies for rare renal diseases. The partnership will combine Protalix's expertise in rare disease biologics with Secarna's AI-powered OligoCreator platform to discover and advance new pharmaceutical candidates. Under the agreement, Protalix is granted an exclusive option to license any active compounds resulting from the research for clinical development and commercialization, marking Protalix's first expansion into rare kidney disease therapies using RNA technologies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL3sZgZP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2585117664","title":"Protalix BioTherapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2585117664","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585117664?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:31","pubTimestamp":1763724660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 21, 2025 06:31 ET (11:31 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX"],"gpt_icon":0},{"id":"2585422112","title":"Protalix price target lowered to $12 from $15 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2585422112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585422112?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:10","pubTimestamp":1763723430,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on Protalix (PLX) to $12 from $15 and keeps a Buy rating on the shares f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protalix-price-target-lowered-to-12-from-15-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protalix-price-target-lowered-to-12-from-15-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2584922820","title":"Protalix BioTherapeutics Q3 EPS USD 0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2584922820","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584922820?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:37","pubTimestamp":1763573856,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - Protalix BioTherapeutics Q3 pretax profit USD 2.239 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-NOV-202511:00:00.18 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD6SWMs1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}]}}